Residency · Madison, WI
Sponsored by University of Wisconsin Hospitals and Clinics
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial.
The Lancet. Neurology · 2021 · 399 citations · Jennifer Kwon
Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial.
Nature medicine · 2022 · 263 citations · Jennifer Kwon
Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial.
Nature medicine · 2022 · 236 citations · Jennifer Kwon
Pediatric neuromodulation for drug-resistant epilepsy: Survey of current practices, techniques, and outcomes across US epilepsy centers.
Epilepsia open · 2024 · 29 citations · Andrew Knox
Vestibular Migraine of Childhood and Recurrent Vertigo of Childhood: Diagnostic criteria Consensus document of the Committee for the Classification of Vestibular Disorders of the Bárány Society and the International Headache Society.
Journal of vestibular research : equilibrium & orientation · 2021 · 75 citations · Kenneth Mack
Real-world, long-term evaluation of the tolerability and therapy retention of Epidiolex® (cannabidiol) in patients with refractory epilepsy.
Epilepsy & behavior : E&B · 2023 · 37 citations · David Hsu
Prevalence of SARS-CoV-2 in human post-mortem ocular tissues.
The ocular surface · 2021 · 96 citations · Azara Singh
Neuromonitoring practices for neonates with congenital heart disease: a scoping review.
Pediatric research · 2025 · 15 citations · Melisa Carrasco